1) Nelson, D. L.; Cox, M. M. (2000). Lehninger, Principles of Biochemistry (3rd ed.). New York: Worth Publishing.
2) Nordestgaard, BG; Varbo, A (August 2014). “Triglycerides and cardiovascular disease”. The Lancet. 384 (9943): 626–35.
3) Blair, HA; Dhillon, S (Oct 2014). “Omega-3 carboxylic acids: a review of its use in patients with severe hypertriglyceridemia”. Am J Cardiovasc Drugs. 14 (5): 393–400.
4) Libby P. (2015). Triglycerides on the rise: should we swap seats on the seesaw?. European heart journal, 36(13), 774–776.
5) Mette Thomsen, Anette Varbo, Anne Tybjærg-Hansen, Børge G Nordestgaard, Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization Study, Clinical Chemistry, Volume 60, Issue 5, 1 May 2014, Pages 737–746,
6) Parthasarathy, V., Frazier, D. T., Bettcher, B. M., Jastrzab, L., Chao, L., Reed, B., Mungas, D., Weiner, M., DeCarli, C., Chui, H., & Kramer, J. H. (2017). Triglycerides are negatively correlated with cognitive function in nondemented aging adults. Neuropsychology, 31(6), 682–688.
7) Elizabeth J. Parks, Effect of Dietary Carbohydrate on Triglyceride Metabolism in Humans, The Journal of Nutrition, Volume 131, Issue 10, October 2001, Pages 2772S–2774S.
8) McBride P. Triglycerides and risk for coronary artery disease. Curr Atheroscler Rep. 2008;10(5):386-390.
9) Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990.
10) Talayero, Beatriz & Sacks, Frank. (2011). The Role of Triglycerides in Atherosclerosis. Current cardiology reports. 13. 544-52. 10.1007/s11886-011-0220-3.
